Treatment Options for Chronic GVHD (cGVHD): Evaluating Axatilimab (Anti-CSF-1R Antibody) Potential in Third Line or Greater

home / precision-medicine / treatment-options-for-chronic-gvhd-cgvhd-evaluating-axatilimab-anti-csf-1r-antibody-potential

Experts on hematologic malignancies have a comprehensive discussion on chronic graft-versus-host disease, focusing on clinical trial data, treatment practices, and the evolving therapeutic landscape.

Corey Cutler, MD, MPH, and Hannah Choe, MD, experts on GVHD

EP. 1: Overview of Acute/Chronic GVHD

Corey S. Cutler, MD, MPH, FRCPC;Hannah Choe, MD
June 28th 2024

Corey Cutler, MD, MPH, and Hannah Choe, MD, provide an overview of chronic graft-vs-host disease (GVHD) and identify characteristics that differentiate it from acute GVHD.

Watch

Corey Cutler, MD, MPH, and Hannah Choe, MD, experts on GVHD

EP. 2: Review of MOA and Effectiveness of Current Treatments

Corey S. Cutler, MD, MPH, FRCPC;Hannah Choe, MD
June 28th 2024

Hematologic oncologists review therapeutic options for patients with chronic GVHD and provide clinical insights on their treatment approaches.

Watch